Skip to main content
SpringerLink
Log in

In vitro activity of antifungal azoles againstHelicobacter pylori

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ: Attempt to fulfill Koch's postulates for pyloric campylobacter. Medical Journal of Australia 1985, 142: 436–443.

    Google Scholar 

  2. Borody TJ, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, Brandl S, Borody EG, George LL: Recurrence of duodenal ulcer andCampylobacter pylori infection after eradication. Medical Journal of Australia 1989, 151: 431–435.

    PubMed  Google Scholar 

  3. Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 1990, 336: 1233–1235.

    Article  Google Scholar 

  4. Glupczynski Y, Burette A, Koster ED, Nyst JF, Deltenre M, Cadranel S, Bourdeaux L, de Vos D: Metronidazole resistance inHelicobacter pylori. Lancet 1990, 336: 976–977.

    Article  PubMed  Google Scholar 

  5. Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, Tamura T, Imada A: Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity againstHelicobacter pylori. Antimicrobial Agents and Chemotherapy 1991, 35: 490–496.

    PubMed  Google Scholar 

  6. Unge P, Gad A, Gnarpe H, Olsson J: Does omeprazole improve antimicrobial therapy directed towards gastricCampylobacter pylori in patients with antral gastritis? Scandinavian Journal of Gastroenterology 1989, 24, Supplement 167: 49–54.

    Google Scholar 

  7. Jones BM, Geary I, Lee ME, Duerden BI: Comparison of the in vitro activities of fenticonazole, other imidazoles, metronidazole, and tetracycline against organisms associated with bacterial vaginosis and skin infections. Antimicrobial Agents and Chemotherapy 1989, 33: 970–972.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bacteriology and Immunology, University of Helsinki, Haartmaninkatu 3, 00290, Helsinki, Finland

    H. Rautelin, M. Vaara, O. V. Renkonen & T. U. Kosunen

  2. Second Department of Medicine, University of Helsinki, Haartmaninkatu 3, 00290, Helsinki, Finland

    K. Seppälä

Authors
  1. H. Rautelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Vaara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. V. Renkonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. U. Kosunen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Seppälä
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rautelin, H., Vaara, M., Renkonen, O.V. et al. In vitro activity of antifungal azoles againstHelicobacter pylori . Eur. J. Clin. Microbiol. Infect. Dis. 11, 273–274 (1992). https://doi.org/10.1007/BF02098101

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02098101

Keywords

Search

Navigation